Symbols / SYRA $0.28 +24.72% Syra Health Corp.
SYRA Chart
About
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering targeted assignments, education, and monitoring symptoms, as well as providing interventions, such as cognitive behavioral therapy and mindfulness techniques; digital health products, including SyraBot, a chatbot to foster connectivity and engagement throughout individuals' care journeys offering members access to necessary information via its AI-powered customer support chat system; and CarePlus, an electronic medical records solution for small to mid-sized healthcare organizations. It also provides analytics as a service, analytics as a service, epidemiology, and health equity analytics solutions. In addition, the company offers medical communications, patient education, and healthcare training; and recruits nurses and allied health professionals for long-term fixed contract positions at hospitals and healthcare facilities. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. The company was incorporated in 2020 and is headquartered in Carmel, Indiana.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Care Facilities | Market Cap | 3.34M |
| Enterprise Value | 2.68M | Income | -896.33K | Sales | 7.23M |
| Book/sh | 0.12 | Cash/sh | 0.09 | Dividend Yield | — |
| Payout | 0.00% | Employees | 38 | IPO | — |
| P/E | — | Forward P/E | -0.90 | PEG | — |
| P/S | 0.46 | P/B | 2.31 | P/C | — |
| EV/EBITDA | -3.04 | EV/Sales | 0.37 | Quick Ratio | 3.75 |
| Current Ratio | 4.06 | Debt/Eq | 6.85 | LT Debt/Eq | — |
| EPS (ttm) | -0.08 | EPS next Y | -0.31 | EPS Growth | — |
| Revenue Growth | -13.60% | Earnings | 2025-03-11 07:00 | ROA | -17.52% |
| ROE | -36.02% | ROIC | — | Gross Margin | 34.43% |
| Oper. Margin | -7.82% | Profit Margin | -12.40% | Shs Outstand | 11.34M |
| Shs Float | 6.81M | Short Float | 4.10% | Short Ratio | 1.68 |
| Short Interest | — | 52W High | 0.28 | 52W Low | 0.03 |
| Beta | 1.12 | Avg Volume | 17.11K | Volume | 77.48K |
| Target Price | — | Recom | None | Prev Close | $0.22 |
| Price | $0.28 | Change | 24.72% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Indiana patients can reach licensed therapists through Syra's app - Stock Titan hu, 02 Apr 2026 20
- Syra Health’s attempt to surpass $0.22 falls short due to low trading volume—Does $0.27 represent a false signal or a real turning point? - Bitget hu, 02 Apr 2026 06
- Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve - PR Newswire Wed, 12 Nov 2025 08
- Syra Health slashes losses 76% and aims to turn a profit by 2026 - Stock Titan hu, 12 Mar 2026 07
- Most and least shorted healthcare stocks with up to $2B market cap - Seeking Alpha Mon, 16 Feb 2026 08
- SYRA Stock Price and Chart — OTC:SYRA - TradingView Wed, 23 Apr 2025 03
- Syra Health Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com Wed, 11 Mar 2026 07
- Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026 - ChartMill hu, 12 Mar 2026 07
- Syra Health (SYRA) cuts FY2025 net loss 76% as margins expand - Stock Titan hu, 12 Mar 2026 07
- Carmel-based health tech firm to delist from Nasdaq - Indianapolis Business Journal ue, 01 Apr 2025 07
- Syra Health reports $1.7M growth in population health unit in 2024 - MobiHealthNews ue, 11 Mar 2025 07
- Syra Health (SYRA) Stock Price, News & Analysis - MarketBeat Fri, 29 Sep 2023 23
- Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market - PR Newswire ue, 01 Apr 2025 07
- Vaccines Gave Us Back Our Tomorrows. We’re Squandering Them - nyas.org Wed, 19 Nov 2025 08
- Syra Health (OTCQB: SYRA) sets Nov. 12 reporting date for Third Quarter 2025 results - Stock Titan Wed, 05 Nov 2025 08
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
7.23
-9.47%
|
7.98
+44.73%
|
5.52
-1.83%
|
5.62
|
| Operating Revenue |
|
7.23
-9.47%
|
7.98
+44.73%
|
5.52
-1.83%
|
5.62
|
| Cost Of Revenue |
|
4.74
-25.14%
|
6.33
+54.25%
|
4.10
-9.94%
|
4.56
|
| Reconciled Cost Of Revenue |
|
4.74
-25.14%
|
6.33
+54.25%
|
4.10
-9.94%
|
4.56
|
| Gross Profit |
|
2.49
+50.50%
|
1.65
+17.07%
|
1.41
+32.97%
|
1.06
|
| Operating Expense |
|
3.39
-37.39%
|
5.42
+26.01%
|
4.30
+36.43%
|
3.15
|
| Research And Development |
|
0.07
-88.41%
|
0.59
+143.76%
|
0.24
|
0.00
|
| Selling General And Administration |
|
3.30
-30.74%
|
4.77
+18.93%
|
4.01
+29.13%
|
3.11
|
| Selling And Marketing Expense |
|
—
|
—
|
—
|
0.39
|
| General And Administrative Expense |
|
3.30
-30.74%
|
4.77
+18.93%
|
4.01
+29.13%
|
3.11
|
| Salaries And Wages |
|
1.50
-44.80%
|
2.72
+16.93%
|
2.33
+52.47%
|
1.52
|
| Other Gand A |
|
1.33
-8.48%
|
1.45
+2.74%
|
1.41
-0.90%
|
1.43
|
| Other Operating Expenses |
|
—
|
—
|
0.00
-89.04%
|
0.03
|
| Total Expenses |
|
8.13
-30.79%
|
11.75
+39.80%
|
8.40
+9.02%
|
7.71
|
| Operating Income |
|
-0.90
+75.98%
|
-3.76
-30.38%
|
-2.89
-38.18%
|
-2.09
|
| Total Operating Income As Reported |
|
-0.90
+75.98%
|
-3.76
-30.38%
|
-2.89
-38.18%
|
-2.09
|
| EBITDA |
|
-0.86
+76.57%
|
-3.68
-29.80%
|
-2.84
-36.68%
|
-2.07
|
| Normalized EBITDA |
|
-0.86
+76.57%
|
-3.68
-29.80%
|
-2.84
-36.68%
|
-2.07
|
| Reconciled Depreciation |
|
0.02
-67.38%
|
0.06
+28.64%
|
0.05
+228.45%
|
0.01
|
| EBIT |
|
-0.88
+76.41%
|
-3.74
-29.78%
|
-2.88
-38.05%
|
-2.09
|
| Net Income |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Pretax Income |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Net Non Operating Interest Income Expense |
|
0.01
+41.51%
|
0.01
+111.13%
|
-0.05
-78.24%
|
-0.03
|
| Interest Expense Non Operating |
|
0.01
-14.94%
|
0.02
-70.94%
|
0.05
+88.15%
|
0.03
|
| Net Interest Income |
|
0.01
+41.51%
|
0.01
+111.13%
|
-0.05
-78.24%
|
-0.03
|
| Interest Expense |
|
0.01
-14.94%
|
0.02
-70.94%
|
0.05
+88.15%
|
0.03
|
| Interest Income Non Operating |
|
0.02
+0.07%
|
0.02
+622.20%
|
0.00
+4569.84%
|
0.00
|
| Interest Income |
|
0.02
+0.07%
|
0.02
+622.20%
|
0.00
+4569.84%
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Net Income From Continuing Operation Net Minority Interest |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Net Income From Continuing And Discontinued Operation |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Net Income Continuous Operations |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Normalized Income |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Net Income Common Stockholders |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Diluted EPS |
|
—
|
-0.50
+16.67%
|
-0.60
-66.00%
|
-0.36
|
| Basic EPS |
|
—
|
-0.50
+16.67%
|
-0.60
-66.00%
|
-0.36
|
| Basic Average Shares |
|
—
|
7.55
+54.81%
|
4.88
-16.77%
|
5.86
|
| Diluted Average Shares |
|
—
|
7.55
+54.81%
|
4.88
-33.02%
|
7.28
|
| Diluted NI Availto Com Stockholders |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Depreciation Amortization Depletion Income Statement |
|
0.02
-67.38%
|
0.06
+28.64%
|
0.05
+228.45%
|
0.01
|
| Depreciation And Amortization In Income Statement |
|
0.02
-67.38%
|
0.06
+28.64%
|
0.05
+228.45%
|
0.01
|
| Depreciation Income Statement |
|
0.02
-67.38%
|
0.06
+28.64%
|
0.05
+228.45%
|
0.01
|
| Insurance And Claims |
|
0.36
-20.67%
|
0.46
+195.65%
|
0.15
+223.33%
|
0.05
|
| Rent And Landing Fees |
|
0.11
-21.53%
|
0.14
+21.14%
|
0.12
+10.10%
|
0.11
|
| Rent Expense Supplemental |
|
0.11
-21.53%
|
0.14
+21.14%
|
0.12
+10.10%
|
0.11
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
4.92
|
| Current Assets |
|
4.78
|
| Cash Cash Equivalents And Short Term Investments |
|
3.28
|
| Cash And Cash Equivalents |
|
3.28
|
| Cash Financial |
|
3.28
|
| Receivables |
|
1.18
|
| Accounts Receivable |
|
1.06
|
| Gross Accounts Receivable |
|
1.07
|
| Allowance For Doubtful Accounts Receivable |
|
-0.01
|
| Taxes Receivable |
|
0.07
|
| Prepaid Assets |
|
0.32
|
| Other Current Assets |
|
0.32
|
| Total Non Current Assets |
|
0.14
|
| Net PPE |
|
0.14
|
| Gross PPE |
|
0.21
|
| Accumulated Depreciation |
|
-0.06
|
| Properties |
|
0.00
|
| Buildings And Improvements |
|
0.06
|
| Machinery Furniture Equipment |
|
0.08
|
| Other Properties |
|
—
|
| Leases |
|
0.06
|
| Non Current Deferred Assets |
|
0.00
|
| Total Liabilities Net Minority Interest |
|
0.91
|
| Current Liabilities |
|
0.91
|
| Payables And Accrued Expenses |
|
0.66
|
| Payables |
|
0.46
|
| Accounts Payable |
|
0.46
|
| Current Accrued Expenses |
|
0.20
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
—
|
| Total Tax Payable |
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.25
|
| Current Debt |
|
0.18
|
| Other Current Borrowings |
|
—
|
| Current Capital Lease Obligation |
|
0.06
|
| Current Deferred Liabilities |
|
0.00
|
| Current Deferred Revenue |
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.00
|
| Stockholders Equity |
|
4.01
|
| Common Stock Equity |
|
4.01
|
| Capital Stock |
|
0.01
|
| Common Stock |
|
0.01
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
6.42
|
| Ordinary Shares Number |
|
6.42
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
9.07
|
| Retained Earnings |
|
-5.06
|
| Total Equity Gross Minority Interest |
|
4.01
|
| Total Capitalization |
|
4.01
|
| Working Capital |
|
3.87
|
| Invested Capital |
|
4.20
|
| Total Debt |
|
0.25
|
| Net Debt |
|
—
|
| Capital Lease Obligations |
|
0.06
|
| Net Tangible Assets |
|
4.01
|
| Tangible Book Value |
|
4.01
|
| Current Notes Payable |
|
0.18
|
| Duefrom Related Parties Current |
|
0.05
|
| Dueto Related Parties Current |
|
—
|
| Interest Payable |
|
0.00
|
| Line Of Credit |
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-0.45
+84.73%
|
-2.93
-6.27%
|
-2.76
-22.95%
|
-2.24
|
| Cash Flow From Continuing Operating Activities |
|
-0.45
+84.73%
|
-2.93
-6.27%
|
-2.76
-22.95%
|
-2.24
|
| Net Income From Continuing Operations |
|
-0.90
+76.16%
|
-3.76
-27.94%
|
-2.94
-38.72%
|
-2.12
|
| Depreciation Amortization Depletion |
|
0.02
-67.38%
|
0.06
+28.64%
|
0.05
+228.45%
|
0.01
|
| Depreciation |
|
0.02
-67.38%
|
0.06
+28.64%
|
0.05
+228.45%
|
0.01
|
| Depreciation And Amortization |
|
0.02
-67.38%
|
0.06
+28.64%
|
0.05
+228.45%
|
0.01
|
| Other Non Cash Items |
|
0.00
-98.39%
|
0.16
+32.86%
|
0.12
-80.46%
|
0.62
|
| Stock Based Compensation |
|
0.10
+64.80%
|
0.06
+82.15%
|
0.03
+1028.21%
|
0.00
|
| Change In Working Capital |
|
0.33
-39.87%
|
0.54
+2422.28%
|
-0.02
+96.93%
|
-0.76
|
| Change In Receivables |
|
-0.24
-155.19%
|
0.43
+490.72%
|
-0.11
+88.29%
|
-0.94
|
| Changes In Account Receivables |
|
-0.24
-155.19%
|
0.43
+490.72%
|
-0.11
+88.29%
|
-0.94
|
| Change In Payables And Accrued Expense |
|
0.18
+159.64%
|
-0.31
-6569.71%
|
0.00
-99.00%
|
0.47
|
| Change In Accrued Expense |
|
-0.04
-163.88%
|
0.06
+345.48%
|
-0.02
-113.86%
|
0.16
|
| Change In Payable |
|
0.22
+160.29%
|
-0.36
-1418.47%
|
0.03
-91.16%
|
0.31
|
| Change In Account Payable |
|
0.22
+160.29%
|
-0.36
-1418.47%
|
0.03
-91.16%
|
0.31
|
| Change In Other Working Capital |
|
—
|
0.02
|
—
|
—
|
| Change In Other Current Assets |
|
0.49
-0.80%
|
0.49
+142.18%
|
0.20
+201.15%
|
-0.20
|
| Change In Other Current Liabilities |
|
-0.11
-18.07%
|
-0.09
+26.09%
|
-0.12
-26.71%
|
-0.10
|
| Investing Cash Flow |
|
-0.00
+99.04%
|
-0.01
+27.15%
|
-0.02
+87.42%
|
-0.12
|
| Cash Flow From Continuing Investing Activities |
|
-0.00
+99.04%
|
-0.01
+27.15%
|
-0.02
+87.42%
|
-0.12
|
| Net PPE Purchase And Sale |
|
-0.00
+99.04%
|
-0.01
+27.15%
|
-0.02
+87.42%
|
-0.12
|
| Purchase Of PPE |
|
-0.00
+99.04%
|
-0.01
+27.15%
|
-0.02
+87.42%
|
-0.12
|
| Capital Expenditure |
|
-0.00
+99.04%
|
-0.01
+27.15%
|
-0.02
+87.42%
|
-0.12
|
| Financing Cash Flow |
|
-0.33
-116.17%
|
2.06
-65.98%
|
6.05
+166.72%
|
2.27
|
| Cash Flow From Continuing Financing Activities |
|
-0.33
-116.17%
|
2.06
-65.98%
|
6.05
+166.72%
|
2.27
|
| Net Issuance Payments Of Debt |
|
-0.35
+15.35%
|
-0.41
-179.17%
|
0.52
-29.56%
|
0.74
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
1.75
-37.75%
|
2.82
|
| Repayment Of Debt |
|
-0.35
+15.35%
|
-0.41
+66.78%
|
-1.24
+40.65%
|
-2.08
|
| Long Term Debt Issuance |
|
—
|
—
|
1.46
|
0.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
-0.29
|
| Net Long Term Debt Issuance |
|
—
|
—
|
1.46
|
0.00
|
| Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
1.75
-37.75%
|
2.82
|
| Short Term Debt Payments |
|
-0.35
+15.35%
|
-0.41
+66.78%
|
-1.24
+40.65%
|
-2.08
|
| Net Short Term Debt Issuance |
|
-0.35
+15.35%
|
-0.41
-179.17%
|
0.52
-29.56%
|
0.74
|
| Net Common Stock Issuance |
|
0.01
-99.40%
|
2.47
-53.69%
|
5.33
+129.59%
|
2.32
|
| Net Other Financing Charges |
|
—
|
—
|
0.20
+125.31%
|
-0.79
|
| Changes In Cash |
|
-0.78
+11.76%
|
-0.88
-127.00%
|
3.28
+3489.67%
|
-0.10
|
| Beginning Cash Position |
|
2.40
-26.97%
|
3.28
+97988.37%
|
0.00
-96.66%
|
0.10
|
| End Cash Position |
|
1.61
-32.59%
|
2.40
-26.97%
|
3.28
+97988.37%
|
0.00
|
| Free Cash Flow |
|
-0.45
+84.78%
|
-2.94
-6.09%
|
-2.77
-17.29%
|
-2.37
|
| Interest Paid Supplemental Data |
|
0.01
-14.94%
|
0.02
-56.94%
|
0.04
+210.93%
|
0.01
|
| Income Tax Paid Supplemental Data |
|
—
|
—
|
—
|
0.00
|
| Common Stock Issuance |
|
0.01
-99.40%
|
2.47
-53.69%
|
5.33
+129.59%
|
2.32
|
| Issuance Of Capital Stock |
|
0.01
-99.40%
|
2.47
-53.69%
|
5.33
+129.59%
|
2.32
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-12 View
- 8-K2026-03-12 View
- 42026-02-03 View
- 8-K2025-12-18 View
- 42025-11-25 View
- 42025-11-25 View
- 42025-11-25 View
- 8-K2025-11-18 View
- 8-K2025-11-14 View
- 10-Q2025-11-12 View
- 8-K2025-11-12 View
- 8-K2025-08-15 View
- 10-Q2025-08-12 View
- 8-K2025-08-12 View
- 8-K2025-07-30 View
- 8-K2025-06-17 View
- 8-K2025-05-20 View
- 8-K2025-05-08 View
- 10-Q2025-05-08 View
- 8-K2025-05-01 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|